|
Dec 2
|
2 Dividend Stocks to Buy and Hold Forever
|
|
Dec 2
|
5 S&P 500 Stocks That Pay a Generous Dividend
|
|
Dec 1
|
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q3 2023 Earnings Call Transcript
|
|
Dec 1
|
Pharma Stock Roundup: ABBV to Buy Immunogen, NVS Ups Mid-Term Sales View & More
|
|
Dec 1
|
AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion
|
|
Dec 1
|
AbbVie Stock (NYSE:ABBV): Bet on a Smart Drugmaker and Dealmaker
|
|
Dec 1
|
Why Abbvie Stock Popped Today
|
|
Nov 30
|
AbbVie To Buy ImmunoGen, Cancer Drug Maker, In $10.1 Billion Cash Deal
|
|
Nov 30
|
This Combination of 3 Stocks Provides Monthly Income
|
|
Nov 30
|
AbbVie to acquire ImmunoGen in $10B deal
|
|
Nov 30
|
AbbVie (ABBV) Posts Encouraging Data From Lung Cancer Study
|
|
Nov 30
|
AbbVie Pays $10.1 Billion for ImmunoGen to Expand Its Cancer Drug Portfolio
|
|
Nov 30
|
Is it a Good Idea to Invest in Harpoon (HARP) Stock Now?
|
|
Nov 30
|
ImmunoGen Stock Soars 81% on AbbVie’s $10.1 Billion Takeover
|
|
Nov 30
|
AbbVie to Buy Cancer Biotech ImmunoGen for More Than $10 Billion
|
|
Nov 30
|
The Zacks Analyst Blog Highlights AbbVie, J&J, Eli Lilly, Pfizer
|
|
Nov 30
|
Biotech Stocks Rally After $10.1 Billion ImmunoGen Buyout
|
|
Nov 30
|
Drugmaker AbbVie to spend over $10B on ImmunoGen to juice its cancer-fighting treatment portfolio
|
|
Nov 30
|
AbbVie Should Consider a Dividend Cut -- Here's Why
|
|
Nov 30
|
AbbVie seeks lift from 'guided missile' cancer drug with $10 billion ImmunoGen deal
|